SC 13G | 2010-01-29 | BlackRock Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,362,637 | 5.6% | EDGAR |
SC 13G/A | 2009-02-17 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 6,211,963 | 15.0% | EDGAR |
SC 13G/A | 2009-02-17 | Aletheia Research & Management, Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,791,191 | 6.7% | EDGAR |
SC 13G/A | 2009-02-09 | NOVARTIS AG | ALNYLAM PHARMACEUTICALS, INC. | 5,481,753 | 13.2% | EDGAR |
SC 13G | 2009-02-05 | BARCLAYS GLOBAL INVESTORS NA /CA/ | ALNYLAM PHARMACEUTICALS, INC. | 875,163 | 2.1% | EDGAR |
SC 13G/A | 2008-02-14 | FMR LLC | ALNYLAM PHARMACEUTICALS, INC. | 6,104,982 | 15.0% | EDGAR |
SC 13G/A | 2008-02-14 | Aletheia Research & Management, Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,748,469 | 6.8% | EDGAR |
SC 13G/A | 2008-02-13 | Abingworth Management LTD | ALNYLAM PHARMACEUTICALS, INC. | - | - | EDGAR |
SC 13G | 2007-06-08 | Aletheia Research & Management, Inc. | ALNYLAM PHARMACEUTICALS, INC. | 2,443,996 | 6.5% | EDGAR |
SC 13D/A | 2007-02-14 | CHP II LP | ALNYLAM PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2007-02-14 | FMR CORP | ALNYLAM PHARMACEUTICALS, INC. | 5,549,610 | 15.0% | EDGAR |
SC 13G/A | 2007-02-14 | ARCH VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | - | - | EDGAR |
SC 13G/A | 2007-02-13 | Abingworth Management LTD | ALNYLAM PHARMACEUTICALS, INC. | 2,040,000 | 6.3% | EDGAR |
SC 13G/A | 2007-02-12 | ATLAS VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | - | - | EDGAR |
SC 13G/A | 2006-02-23 | POLARIS VENTURE PARTNERS III LP | ALNYLAM PHARMACEUTICALS, INC. | 365,852 | 1.4% | EDGAR |
SC 13D/A | 2006-02-15 | CHP II LP | ALNYLAM PHARMACEUTICALS, INC. | 1,391,870 | 6.6% | EDGAR |
SC 13G/A | 2006-02-14 | FMR CORP | ALNYLAM PHARMACEUTICALS, INC. | 3,461,987 | 13.0% | EDGAR |
SC 13G/A | 2006-02-14 | POLARIS VENTURE PARTNERS III LP | ALNYLAM PHARMACEUTICALS, INC. | 1,938,532 | 7.3% | EDGAR |
SC 13G/A | 2006-02-14 | ARCH VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | 1,532,697 | 5.8% | EDGAR |
SC 13G/A | 2006-02-13 | Abingworth Management LTD | ALNYLAM PHARMACEUTICALS, INC. | 2,150,000 | 10.3% | EDGAR |